About Modular Genetics
Modular Genetics is a Healthcare company based in Woburn (United States) founded in 2000. Proprietary automated systems for gene engineering are developed. Modular Genetics has raised $7.5 million across 10 funding rounds from investors including Boston University, MassVentures and National Science Foundation. The company has 7 employees. Modular Genetics offers products and services including Automated Gene Engineering System and Engineered Microorganisms. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Assays and Drug Discovery. Its legal entity is Modular Genetics, Inc. Its competitors include Poseida Therapeutics, Senti Biosciences and ADARx Pharmaceuticals; 3 of its 3 listed competitors have raised funding.
Company details
Modular Genetics was founded in 2000 and is based in Woburn, United States. Operations focus on the biotechnology sector, where a platform known as CombiGenix is utilized to synthesize, modify, and recombine genes into novel recombinant DNA molecules. These are integrated with protein design and high-throughput screening processes to enable automated protein evolution. Applications span synthetic biology, industrial biotechnology, and protein therapeutics.
- Headquarters Woburn, United States
- Employees 7
- SectorsHealthcare
- Website modulargenetics.com
- Social LinkedIn
- Legal Name Modular Genetics, Inc.
- Total Equity Funding$7.5M (USD)
in 10 rounds
- Latest Funding Round$100K (USD), Grant
Aug 2016
- InvestorsBoston University
& 3 more
- Employee Count7
Products & Services of Modular Genetics
Modular Genetics offers a comprehensive portfolio of products and services, including Automated Gene Engineering System and Engineered Microorganisms.
System for developing engineered microorganisms to synthesize chemicals from renewables.
Microbes designed for chemical production using affordable raw materials.
Funding Insights of Modular Genetics
Modular Genetics has successfully raised a total of $7.5M across 10 strategic funding rounds. The most recent funding activity was a Grant round of $100 thousand completed in August 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $7.5M
- Total Rounds 10
- Last Round Grant — $100,000
- First Round $5.5M
(Jun 2004)
- Investors Count 4
All 10 funding rounds of Modular Genetics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2016 | $100,000 | Grant | – | – | |
| Jul 2016 | $225,000 | Grant | – | – | |
| May 2014 | $1.62M | Grant | – | – | |
| Jan 2014 | $1.6M | Grant | – | – | |
| Jan 2013 | $150,000 | Grant | – | – | |
| Aug 2010 | $200,000 | Grant | – | – | |
| Oct 2008 | $201,300 | Debt – Convertible | – | – | – |
| Jan 2008 | $1.19M | Debt – Convertible | – | – | – |
| Mar 2005 | $2M | Series B | – | – | – |
| Jun 2004 | $5.5M | Series B | – | – |
4 investors in total: 4 institutional.
Investors in Modular Genetics
Modular Genetics has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Boston University, MassVentures and National Science Foundation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Tech focused early stage VC firm investing in the US | mass-ventures.com | Boston, United States | ||
Venture capital fund backed by the US Government | seedfund.nsf.gov | Alexandria, United States | ||
A government-backed foundation providing seed-stage investments to support small businesses. | 1950 | nsf.gov | Arlington, United States | |
Multiple courses and degrees are offered across diversified academic streams. | 1869 | bu.edu | United States |
Investor details for Modular Genetics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Modular Genetics
3 dated milestones of Modular Genetics across 16 years, from founding to its latest funding, stage changes and deals.
- Founded Modular Genetics is founded.
- Funding First funding round of $5.5M.
- Funding Latest funding round, Grant, of $100K.
Competitors of Modular Genetics
Modular Genetics has 3 listed competitors in our database, 3 of them funded. They include Poseida Therapeutics, Senti Biosciences and ADARx Pharmaceuticals.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| poseida.com | 2015 | San Diego, United States | $323.78M | 259 | Developer of gene therapies for treating cancer and liver orphan disease by using gene editing technologies | |
| sentibio.com | 2016 | San Francisco, United States | $158M | Cell-based therapies for cancer treatment are developed. | ||
| adarx.com | 2019 | San Diego, United States | $352.5M | 44 | Developer of genetic therapeutic solutions to edit single point mutations on RNA transcripts |
Detailed competitors of Modular Genetics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Modular Genetics
Websites that share an audience with Modular Genetics (modulargenetics.com).
Websites whose visitors overlap most with Modular Genetics. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| sloning.com | 100% | View details | |||
| genaxxon.com | 92% | 16.5K | #1,573,860 | View details | |
| excellgene.com | 89% | 1.5K | #10,924,536 | View details |
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Modular Genetics (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Modular Genetics
Complete news archive for Modular Genetics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Modular Genetics
Modular Genetics was founded in 2000 and raised its 1st funding round 4 years after it was founded.
Modular Genetics is headquartered in Woburn, United States. It is registered at Woburn, Massachusetts, United States.
Modular Genetics is a funded company, having raised a total of $7.5M across 10 funding rounds to date. The company's 1st funding round was a Series B of $5.5M, raised on Jun 2004.
Modular Genetics has 7 employees.
Modular Genetics was founded in 2000 and is based in Woburn, United States. Operations focus on the biotechnology sector, where a platform known as CombiGenix is utilized to synthesize, modify, and recombine genes into novel recombinant DNA molecules. These are integrated with protein design and high-throughput screening processes to enable automated protein evolution. Applications span synthetic biology, industrial biotechnology, and protein therapeutics.
Modular Genetics's top competitors include Senti Biosciences, Poseida Therapeutics and ADARx Pharmaceuticals.
Modular Genetics offers Automated Gene Engineering System and Engineered Microorganisms.
Modular Genetics has 4 investors. Key investors include Boston University, MassVentures, National Science Foundation, and America’s Seed Fund.
Modular Genetics operates through Modular Genetics, Inc..